Cassetta, L. et al.

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.

Cancer Cell, 2019. 35(4): 588-602 e10.

Cassetta, L. and Pollard J.W.

Targeting macrophages: therapeutic approaches in cancer.

Nat Rev Drug Discov, 2018. 17(12): 887-904.

Hoves, S. et al.

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.

J Exp Med 2018. 215(3): 859-876.

Majety, M. et al.

A drug development perspective on targeting tumor-associated myeloid cells.

FEBS J 2018. 285(4): 763-776.

Kitamura, T. et al.

Immune cell promotion of metastasis.

Nat Rev Immunol, 2015. 15(2): 73-86.

Ries, C.H. et al.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals novel strategy for cancer therapy.

Cancer Cell 2014, 25(6): 846-59, selected for Best of Cancer Cell 2014.

Wynn, T.A. et al.

Macrophage biology in development, homeostasis and disease.

Nature, 2013. 496(7446): 445-55.

Qian, B.Z. et al.

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Nature, 2011. 475(7355): 222-5.

Qian, B.Z. and Pollard J.W.

Macrophage diversity enhances tumor progression and metastasis.

Cell, 2010. 141(1): 39-51.